Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Factbox-Countries vaccinating children against COVID-19

Published 15/10/2021, 16:22
Updated 15/10/2021, 16:25
© Reuters. FILE PHOTO: A healthcare worker administers the Pfizer/BioNTech coronavirus disease (COVID-19) vaccine, which was authorized by Canada to be used for children aged 12 to 15, at Woodbine Racetrack pop-up vaccine clinic in Toronto, Ontario, Canada May 5, 20

(Reuters) - Pfizer Inc (NYSE:PFE) and BioNTech SE have asked U.S. regulators to authorize their COVID-19 vaccine for emergency use in children aged 5-11, with an expert panel to the Food and Drug Administration scheduled to meet later this month to review data.

But with many parts of the world still awaiting doses for more vulnerable people, the World Health Organisation has urged countries and companies that control the global supply of the vaccines to prioritize supply to COVAX.

The following is a list of some countries that have approved or are considering vaccinating children:

EU COUNTRIES

* In June, Denmark said it would offer COVID-19 shots to children aged 12-15 to boost its overall immunity against the virus.

* France has started vaccinating those from 12 years upwards, provided they have parental consent.

* Germany in August agreed to make vaccination available to all children aged 12-17.

* Austria has started vaccinating children aged 12-15.

* Estonia could start vaccinating teenagers by the autumn, public broadcaster ERR reported, citing the head of the government's COVID-19 council.

* Hungary started vaccinating 16 to 18-year-olds in mid-May, according to Xinhua news agency.

* Italy on May 31 approved extending the use of Pfizer's vaccine to 12-15 year olds.

* Lithuania's prime minister said the country could start vaccinating children from age 12 in June, news site Delfi reported.

* Spain begun vaccinating children between 12 and 17 years old around two weeks before the academic year in September, the health minister said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

* Swedish PM says children aged 12-15 will be offered COVID vaccine later this autumn.

* Greece in July said children aged 12-15 could be vaccinated against COVID-19 with Pfizer/BioNTech and Moderna (NASDAQ:MRNA) shots.

* Finland's capital Helsinki in June said it will begin giving COVID-19 vaccines to children aged 12 to 15 who are at risk of contracting a severe coronavirus infection.

EUROPE (NON-EU)

* Britain's top medical advisers in September recommended that 12 to 15-year-olds receive a first dose of a COVID-19 vaccine.

* Switzerland approved on June 4 vaccinating 12 to 15-year-olds with Pfizer's shot, while Moderna's shot was approved in August for the age group.

* In September, Norway started to offer one dose of Pfizer and BioNTech COVID-19 vaccine to children aged 12 to 15

* San Marino has opened vaccinations for children aged 12-15, reported San Marino RTV, citing its Institute for Social Security.

MIDDLE EAST

* In August, Israel on Sunday began offering a COVID-19 booster to children as young as 12.

* The United Arab Emirates said in August rolled out China's Sinopharm COVID-19 vaccine to children aged 3-17.

ASIA-PACIFIC

* Indonesia on June 28 recommended China's Sinovac vaccine for children aged 12-17.

* An advisory committee to the Indian regulator recommended emergency use of Bharat Biotech's COVID-19 shot in the 2 to 18 age-group. The regulator's nod is awaited.

* New Zealand's medicines regulator has provisionally approved use of Pfizer's vaccine for 12-15 year olds, Prime Minister Jacinda Ardern said on June 21.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

* Australia said on Sept. 12 it will expand its COVID-19 vaccination drive to include around one million children aged 12-15.

* China on June 5 approved emergency use of Sinovac's vaccine for those between three and 17.

* Hong Kong said on June 3 it would open its vaccine scheme to children over the age of 12.

* Singapore opened up its vaccination programme to adolescents aged 12-18 from June 1.

* Japan on May 28 approved the use of Pfizer's vaccine for those aged 12 and above.

* The Philippines on May 26 decided to allow the Pfizer-BioNTech's vaccine for emergency use in children aged 12-15.

* Jordan in July begun vaccinating children aged 12 years and older against COVID-19.

AMERICAS

* The COVID-19 vaccine by Pfizer-BioNTech will be the only one used in Mexico for at-risk children aged 12-17.

* Brazil on June 11 approved use of Pfizer's vaccine for children over 12.

* Chile has approved use of Pfizer's vaccine for 12 to 16-year-olds.

* Pfizer and BioNTech have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11. An advisory committee to the FDA will meet later this month to review the data.

* Canada in early May approved use of Pfizer's vaccine for use in children aged 12-15. The country has fully vaccinated more that 80% of its eligible population ages 12 and over.

* Cuba's vaccination campaign includes children as young as two.

AFRICA

* South Africa will start vaccinating children between the ages of 12 and 17 next week using the Pfizer vaccine

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.